HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dou-Sheng Bai Selected Research

Hypersplenism (Anemia, Splenic)

10/2022Robotic-assisted versus laparoscopic approach of Bai-Jiang-style vagus nerve-preserving splenectomy and azygoportal disconnection.
10/2022Clinical effects of cluster technology optimization and innovations on laparoscopic splenectomy and azygoportal disconnection: a single-center retrospective study with 500 consecutive cases.
1/2022Vagus Nerve-Preserving Laparoscopic Splenectomy and Azygoportal Disconnection with Versus Without Intraoperative Endoscopic Variceal Ligation: a Randomized Clinical Trial.
11/2020Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study.
1/2019Adverse factors responsible for below-normal platelet count after laparoscopic splenectomy and azygoportal disconnection.
2/2017Individualized Laparoscopic Therapy for Portal Hypertension: A Preliminary Single Center Experience.
1/2017Laparoscopic and Open Splenectomy and Hepatectomy.
10/2016Laparoscopic azygoportal disconnection with and without splenectomy for portal hypertension.
6/2016Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism.
12/2014Modified laparoscopic splenectomy and azygoportal disconnection combined with cell salvage is feasible and might reduce the need for blood transfusion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dou-Sheng Bai Research Topics

Disease

13Neoplasms (Cancer)
01/2022 - 03/2001
11Fibrosis (Cirrhosis)
10/2022 - 04/2012
11Hypersplenism (Anemia, Splenic)
10/2022 - 01/2014
11Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2009
9Portal Hypertension
10/2022 - 01/2014
9Hemorrhage
10/2022 - 01/2014
7Flatulence
10/2022 - 04/2012
7Thrombosis (Thrombus)
01/2022 - 10/2015
6Neoplasm Metastasis (Metastasis)
08/2021 - 02/2009
4Pain (Aches)
10/2022 - 01/2014
2Fever (Fevers)
01/2022 - 10/2016
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2020 - 01/2014
1Down Syndrome (Down's Syndrome)
01/2022
1Hepatitis B
01/2022
1Cholangiocarcinoma
09/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Carcinogenesis
01/2020
1Lymphatic Metastasis
08/2019
1Thrombocytopenia (Thrombopenia)
01/2019
1Body Weight (Weight, Body)
01/2018
1Varicose Veins (Varicose Vein)
02/2017
1Wounds and Injuries (Trauma)
01/2017
1Hemangioma (Angioma)
11/2015
1Postoperative Hemorrhage
10/2015
1Infections
10/2015
1Pleural Effusion (Pleural Effusions)
10/2015
1Necrosis
08/2014
1Granuloma
08/2014
1Breast Neoplasms (Breast Cancer)
08/2014
1Carcinoma (Carcinomatosis)
08/2013

Drug/Important Bio-Agent (IBA)

11Lysergic Acid Diethylamide (LSD)IBA
10/2022 - 10/2015
5Proteins (Proteins, Gene)FDA Link
08/2019 - 02/2009
3Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 07/2016
2Circular RNAIBA
01/2022 - 09/2021
2Biological FactorsIBA
08/2021 - 01/2021
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021 - 10/2017
2UbiquitinIBA
01/2020 - 05/2016
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2019 - 07/2016
2CalpainIBA
11/2014 - 01/2013
1BuffersIBA
01/2022
1CM 2-3IBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1Gefitinib (Iressa)FDA Link
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020
1GlutaminaseIBA
08/2019
1Messenger RNA (mRNA)IBA
01/2018
1Serum AlbuminIBA
01/2018
1ProcalcitoninIBA
10/2016
1C-Reactive ProteinIBA
10/2016
1Annexin A2 (Annexin II)IBA
05/2016
1Hemoglobins (Hemoglobin)IBA
12/2014
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2014
1Fluorouracil (Carac)FDA LinkGeneric
08/2014
1Pharmaceutical PreparationsIBA
08/2014
1GemcitabineFDA Link
08/2013
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
02/2009
1Biomarkers (Surrogate Marker)IBA
02/2009
1IsotopesIBA
02/2009
1TetraspaninsIBA
02/2009
1ChondroitinIBA
03/2001

Therapy/Procedure

16Splenectomy
10/2022 - 01/2014
9Length of Stay
10/2022 - 04/2012
3Blood Transfusion (Blood Transfusions)
01/2022 - 01/2014
3Hepatectomy
02/2017 - 11/2015
3Therapeutics
02/2017 - 02/2009
2Operative Surgical Procedures
01/2021 - 01/2014
2Drug Therapy (Chemotherapy)
08/2014 - 03/2001
1Autologous Blood Transfusion
12/2014
1Pancreatectomy
08/2013
1Fluid Therapy (Oral Rehydration Therapy)
04/2012
1Liver Transplantation
02/2009